BR112017000312A2 - sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal - Google Patents

sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal

Info

Publication number
BR112017000312A2
BR112017000312A2 BR112017000312A BR112017000312A BR112017000312A2 BR 112017000312 A2 BR112017000312 A2 BR 112017000312A2 BR 112017000312 A BR112017000312 A BR 112017000312A BR 112017000312 A BR112017000312 A BR 112017000312A BR 112017000312 A2 BR112017000312 A2 BR 112017000312A2
Authority
BR
Brazil
Prior art keywords
amino acids
treatment system
oral health
health treatment
calcium phosphate
Prior art date
Application number
BR112017000312A
Other languages
English (en)
Inventor
Mohan Veena
Original Assignee
Koninklijke Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips Nv filed Critical Koninklijke Philips Nv
Publication of BR112017000312A2 publication Critical patent/BR112017000312A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção revela um sistema para fornecer uma formulação ativa para tratamento bucal que aplica fosfato de cálcio amorfo (acp) aos dentes de um indivíduo. o sistema compreende um componente que fornece íons de cálcio e um componente que fornece íons de fosfato. a invenção possibilita obter maiores concentrações de acp como um resultado da inclusão, em um ou ambos os componentes, de um ou mais aminoácidos básicos. a invenção também possibilita fornecer acp através da administração de um verniz à base de solvente de dois componentes.
BR112017000312A 2014-07-11 2015-07-10 sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal BR112017000312A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14176834 2014-07-11
PCT/EP2015/065835 WO2016005559A1 (en) 2014-07-11 2015-07-10 Oral care formulation system providing amorphous calcium phosphate

Publications (1)

Publication Number Publication Date
BR112017000312A2 true BR112017000312A2 (pt) 2017-10-31

Family

ID=51167774

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017000312A BR112017000312A2 (pt) 2014-07-11 2015-07-10 sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal

Country Status (7)

Country Link
US (2) US20170157003A1 (pt)
EP (1) EP3166692B1 (pt)
JP (1) JP6751027B2 (pt)
CN (1) CN106535867B (pt)
BR (1) BR112017000312A2 (pt)
RU (1) RU2017104238A (pt)
WO (1) WO2016005559A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3718529A1 (en) * 2019-04-02 2020-10-07 Koninklijke Philips N.V. Kit for tooth remineralising and dentine hypersensitivity treatment
WO2021059215A2 (en) * 2019-09-25 2021-04-01 Church & Dwight Co., Inc. Oral care composition
CA3154892A1 (en) * 2019-10-30 2021-05-06 Erik UNOSSON Stabilized amorphous calcium magnesium phosphate particle compositions
CN110693724B (zh) * 2019-11-05 2020-10-30 浙江大学 一种牙齿矿化液及其矿化方法
CN113577103B (zh) * 2021-08-11 2022-07-26 浙江大学 一种小尺寸的磷酸钙纤维及其制备方法和应用
EP4292665A1 (en) * 2022-06-16 2023-12-20 Koninklijke Philips N.V. An instantly formed cationic acp gel for treatment of tooth hypersensitivity
WO2023242172A1 (en) * 2022-06-16 2023-12-21 Koninklijke Philips N.V. In situ formed cationic acp gel for treatment of tooth hypersensitivity
WO2023242039A1 (en) * 2022-06-17 2023-12-21 Koninklijke Philips N.V. System for ultrasound enhanced tooth hypersensitivity treatment with cationic composition
EP4292565A1 (en) * 2022-06-17 2023-12-20 Koninklijke Philips N.V. System for ultrasound enhanced tooth hypersensitivity treatment with cationic composition

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE42129B1 (en) * 1974-10-10 1980-06-04 Procter & Gamble Compositions for remineralizing tooth enamel
US6056930A (en) 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5037639A (en) 1989-05-24 1991-08-06 American Dental Association Health Foundation Methods and compositions for mineralizing calcified tissues
US6000341A (en) 1989-05-24 1999-12-14 American Dental Association Health Foundation Methods and composition for mineralizing and fluoridating calcified tissues
US5460803A (en) 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5908614A (en) 1995-08-15 1999-06-01 Montgomery; Robert Eric Peroxidase-activating oral compositions
AU7245596A (en) 1995-09-25 1997-04-17 Robert Eric Montgomery Tooth bleaching compositions
US5713738A (en) 1995-12-12 1998-02-03 Britesmile, Inc. Method for whitening teeth
US5645428A (en) 1995-12-12 1997-07-08 Britesmile, Inc. Method for whitening teeth
US6221341B1 (en) 1997-11-19 2001-04-24 Oraceutical Llc Tooth whitening compositions
US20030198605A1 (en) 1998-02-13 2003-10-23 Montgomery R. Eric Light-activated tooth whitening composition and method of using same
US6416319B1 (en) 1998-02-13 2002-07-09 Britesmile, Inc. Tooth whitening device and method of using same
US6162055A (en) 1998-02-13 2000-12-19 Britesmile, Inc. Light activated tooth whitening composition and method of using same
JP3377768B2 (ja) 1999-05-27 2003-02-17 伊藤忠飼料株式会社 採卵鶏用飼料
US6986883B2 (en) 1999-09-09 2006-01-17 Discus Dental, Inc. Increased peroxide content tooth bleaching gel
CA2383967C (en) 1999-09-09 2012-04-10 Discus Dental, Inc. Increased peroxide content tooth bleaching gel
CN1390112A (zh) 1999-10-08 2003-01-08 布里特斯迈尔公司 同步照射牙齿的装置
US20050175959A1 (en) * 2000-03-14 2005-08-11 Coll Partners Ltd. System for the controlled delivery of an active material to a dental site
WO2004103303A2 (en) 2003-05-16 2004-12-02 Britesmile Development, Inc. Therapeutic dental composition
US20050026107A1 (en) 2003-07-28 2005-02-03 Britesmile Development, Inc. Therapeutic responsive dental gel composition
CA2587077C (en) * 2004-11-09 2014-03-25 Discus Dental Impressions, Inc. Dental whitening systems
MX2007006254A (es) * 2004-11-25 2007-09-07 Univ Melbourne Complejos de fosfato de calcio estabilizados.
US20060292092A1 (en) * 2005-06-22 2006-12-28 Deepak Sharma Oral care compositions, devices, and methods of using the same
JP2011510982A (ja) * 2008-02-08 2011-04-07 コルゲート・パーモリブ・カンパニー 口腔ケア製品ならびにその使用方法および製造方法
US20110014136A1 (en) * 2008-02-08 2011-01-20 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
PL2249784T3 (pl) * 2008-02-08 2016-12-30 Produkt do higieny jamy ustnej i sposoby jego stosowania i wytwarzania
CN103118651B (zh) * 2009-04-27 2016-01-06 普雷米尔牙科产品公司 用于组织矿化的微胶囊化组合物和方法
AU2009346357B2 (en) * 2009-05-18 2012-11-29 Colgate-Palmolive Company Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
TWI382852B (zh) * 2009-12-22 2013-01-21 Univ Taipei Medical 一種口腔保健用磷酸鈣複合物及其製法與組合物
US9757315B2 (en) * 2012-10-31 2017-09-12 Kao Corporation Tooth whitener
US11179299B2 (en) * 2013-11-14 2021-11-23 Koninklijke Philips N.V. System and method for applying oral care agents

Also Published As

Publication number Publication date
EP3166692A1 (en) 2017-05-17
US20200038300A1 (en) 2020-02-06
US20170157003A1 (en) 2017-06-08
EP3166692B1 (en) 2019-11-06
JP6751027B2 (ja) 2020-09-02
CN106535867B (zh) 2020-12-25
WO2016005559A1 (en) 2016-01-14
JP2017519776A (ja) 2017-07-20
RU2017104238A (ru) 2018-08-13
CN106535867A (zh) 2017-03-22

Similar Documents

Publication Publication Date Title
BR112017000312A2 (pt) sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
UY37617A (es) Moduladores de la proteína reguladora de la conductancia transmembrana en fibrosis quística y métodos de empleo
BR112018010720A8 (pt) agonistas do receptor de apelina e métodos de uso
CU20190101A7 (es) Imidazopirimidinas diazabicíclicas sustituidas
BR112017005693A2 (pt) método para tratar e/ou prevenir uma doença hepática, e, composição farmacêutica.
DOP2016000109A (es) Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas.
CR20120255A (es) Derivados de purina o deazapurina útiles para el tratamiento de inter alia infecciones virales
EA201990820A1 (ru) Способы лечения митохондриальных и метаболических нарушений
CL2017002082A1 (es) Nuevas proteínas especificas para pioverdina y pioquelina
BR112015015891A8 (pt) Composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
EA202191513A1 (ru) Снижение вязкости фармацевтических составов
BR112019005328A2 (pt) composição farmacêutica líquida
BR112016021034A8 (pt) composição farmacêutica, uso da mesma e kit
GT201700179A (es) Formulaciones en polvo nasal para el tratamiento de hipoglicemia
BR112019000356A2 (pt) compostos e métodos para modulação de smn2
BR112016006994A2 (pt) inibidores de erk e métodos de uso
BR112019006853A2 (pt) composição farmacêutica líquida
BR112015020139A2 (pt) compostos terapêuticos e usos dos mesmos
BR112017006113A8 (pt) usos de auristatina, composições farmacêuticas, formas de dosagem para o tratamento de câncer e kits.
BR112018000242A2 (pt) composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico
BR112018006873A2 (pt) ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias
BR112016027043A8 (pt) combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer
BR112014019399A2 (pt) métodos de tratamento da fibrose

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired